A dramatic decline in smoking rates has coincided with the introduction of plain-packaging laws in Australia. The daily smoking rate decreased from 15.1 per cent to 12.8 per cent between 2010 and 2013, according to the largest and longest-running national survey on drug statistics. Most people are now 16 before they smoke their first full cigarette, up from 14 in 2010, and 95 per cent of 12 to 17-year-olds have never smoked.
Advertisement
“It’s almost like finding a vaccine that works very well against lung cancer,” said Simon Chapman, a professor in public health at the University of Sydney. “It’s that big. This will give enormous momentum to the international push for plain packaging right around the world.”
The president of the Australian Council on Smoking and Health, Mike Daube, said they were the best results he had seen in his 40-year career in health policy.The National Preventative Health Taskforce in 2009 set a target of 10 per cent adult prevalence by 2018. ” I think we are now going to beat that, and once we’re below 10 per cent I think we will see an even faster decline as smoking essentially becomes an abnormal behaviour,” Professor Daube said.
He attributed the figures to effective media campaigns, tax increases and bipartisan political approach to reducing smoking, as well as the plain packaging laws. “The plain packaging has been a crucial factor in the last two to three years,” he said.
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
WhatisAlpha-1AntitrypsinDeficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
HowDoIGetTested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie
Plunge in smoking in Australia attributed to new plain packaging laws
A dramatic decline in smoking rates has coincided with the introduction of plain-packaging laws in Australia. The daily smoking rate decreased from 15.1 per cent to 12.8 per cent between 2010 and 2013, according to the largest and longest-running national survey on drug statistics. Most people are now 16 before they smoke their first full cigarette, up from 14 in 2010, and 95 per cent of 12 to 17-year-olds have never smoked.
“It’s almost like finding a vaccine that works very well against lung cancer,” said Simon Chapman, a professor in public health at the University of Sydney. “It’s that big. This will give enormous momentum to the international push for plain packaging right around the world.”
The president of the Australian Council on Smoking and Health, Mike Daube, said they were the best results he had seen in his 40-year career in health policy.The National Preventative Health Taskforce in 2009 set a target of 10 per cent adult prevalence by 2018. ” I think we are now going to beat that, and once we’re below 10 per cent I think we will see an even faster decline as smoking essentially becomes an abnormal behaviour,” Professor Daube said.
He attributed the figures to effective media campaigns, tax increases and bipartisan political approach to reducing smoking, as well as the plain packaging laws. “The plain packaging has been a crucial factor in the last two to three years,” he said.
Ireland follows Australia as the second country globally to legislate for the plain packaging of tobacco products. India and France are now also considering plain packaging laws as well as New Zealand and Britain. http://www.smh.com.au/federal-politics/political-news/plunge-in-smoking-attributed-to-plain-packaging-20140716-ztqht.html
Read more: http://www.smh.com.au/federal-politics/political-news/plunge-in-smoking-attributed-to-plain-packaging-20140716-ztqht.html#ixzz398ZoAfmU
Info Centre
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
How Do I Get Tested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie